Both in Pharmaceuticals
Acadia Pharmaceuticals vs Parabilis Medicines
Over the past year ACAD returned −26.1% and PBLS returned −20.7%; their daily moves had a correlation of 0.46.
ACAD −26.1% PBLS −20.7%Growth of $1, one year, split-adjusted
| Metric | ACAD | PBLS |
|---|---|---|
| Price | $20.57 | $29.25 |
| Market cap | $3.54B | $3.61B |
| Today | +0.49% | +7.34% |
| 1 month | +2.3% | −0.9% |
| 6 months | −8.0% | — |
| Year to date | −23.0% | — |
| 1 year | −9.4% | — |
| Revenue growth (YoY) | +16.4% | — |
| Gross margin | 90.8% | 100.0% |
| Net margin | 10.2% | −45239.9% |
| P/E (TTM) | 9.3× | — |
| Price / sales | 3.1× | — |
| Net cash | $956.5M | $1.11B |
| Dividend yield | — | — |
| Volatility (60d) | 43.8% | — |
| Short % of float | 7.1% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).